Navigation Links
Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders
Date:5/13/2010

SEATTLE, May 13 /PRNewswire-FirstCall/ -- Omeros Corporation (Nasdaq: OMER), a clinical-stage biopharmaceutical company, today announced that, based on successful preclinical studies, the Company has selected a clinical candidate for its MASP-2 antibody program and has initiated the cGMP manufacturing development process in preparation for clinical trials. Preclinical studies have shown that Omeros' proprietary, fully human, monoclonal MASP-2 antibodies shut down the lectin pathway of the complement system, which is part of the immune system. The lectin pathway is involved in multiple inflammatory disorders and, in independent studies, patients who are genetically deficient in the pathway have been shown to have better clinical outcomes. MASP-2 inhibition has also demonstrated efficacy across a wide range of preclinical disease models.

"MASP-2 is an exciting target and, with our recent licensing of Helion's intellectual property, we have now consolidated within Omeros the worldwide exclusive rights to MASP-2 inhibition and the antibodies that target the protein," stated Gregory A. Demopulos, M.D., chairman and chief executive officer of Omeros. "The preclinical data support our lead antibody's potential for broad utility in both orphan and major-market diseases. In addition, the clinical utility and commercial value of complement inhibition has been validated by the first and, currently, the only complement antibody on the market."

About Omeros' Program to Inhibit MASP-2 with Fully Human Antibodies

MASP-2 (mannan-binding lectin-associated serine protease-2) is a novel pro-inflammatory protein target in the complement system. Omeros has generated
'/>"/>

SOURCE Omeros Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study
2. Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery
3. Omeros Announces Patient Enrollment in Phase 1/Phase 2 Study of OMS302
4. Omeros and The Parkinsons Institute and Clinical Center Enter into a Collaboration Agreement to Evaluate Novel Target for the Treatment of Movement Disorders
5. Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program
6. Omeros Prices Initial Public Offering of Common Stock at $10.00 Per Share
7. Omeros Announces National Institute on Drug Abuses Support for Phase 2 Clinical Study in Addiction Program
8. Omeros Corporation to Host Third Quarter 2009 Financial Results Conference Call on November 19
9. Daniel K. Spiegelman Elected to Board of Directors of Omeros
10. Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery
11. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... NEW YORK, Aug 20, 2014 Reportlinker.com ... available in its catalogue: Global Patient ... This report analyzes the worldwide markets ... following Product Segments: Floor Scales, Infant & Baby ... report provides separate comprehensive analytics for the US, ...
(Date:8/19/2014)... Aug. 19, 2014   Lincor Inc. ... experience technology to New Jersey ... agreement, CarePoint Health will deploy Lincor,s PatientLINC technology ... Christ Hospital and Hoboken University Medical Center. ... of software solutions to help hospitals reach new ...
(Date:8/19/2014)... , Aug. 19, 2014 /PRNewswire-iReach/ -- ChemImage founder ... present a scientific poster describing an innovative diagnostic procedure ... 2014: Shedding New Light on Disease (SPEC) conference in ... Dr. Treado,s poster entitled, "Development of in vitro Diagnostics ... will be discussed during the conference poster session on ...
Breaking Medicine Technology:Global Patient Scales Industry 2Global Patient Scales Industry 3Global Patient Scales Industry 4Global Patient Scales Industry 5Global Patient Scales Industry 6Global Patient Scales Industry 7Global Patient Scales Industry 8Global Patient Scales Industry 9Global Patient Scales Industry 10Global Patient Scales Industry 11Global Patient Scales Industry 12Global Patient Scales Industry 13Global Patient Scales Industry 14Global Patient Scales Industry 15Global Patient Scales Industry 16Global Patient Scales Industry 17Global Patient Scales Industry 18Global Patient Scales Industry 19Lincor Announces Agreement With CarePoint Health For State-Of-The-Art Patient Engagement Technology 2ChemImage Scientists Present Latest Developments for in vitro Detection of Colorectal Cancer Using Raman Molecular Imaging (RMI) at International Conference Focused on Biomedical Applications of Raman Spectroscopy 2
... CINCINNATI, Ohio , June 29 Dr. Harry J. ... speaker and panel discussion participant at the 2010 Central Regional Meeting of ... June 16-19, 2010 .  The 2010 CeRMACS attracted over 400 participants and ... chemical disciplines.   , , ...
... /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems,Ltd. (Nasdaq: DHRM ), an emerging leader in the ... ,today announced members of its Executive Management will ring the NASDAQ Stock,Market closing bell ... , , ... , , ...
Cached Medicine Technology:Dr. Harry J. Guttman, Esq. Invited Speaker at 2010 Central Regional Meeting of the American Chemical Society 2Dehaier Medical Systems Chief Executive Officer To Ring NASDAQ Stock Market Closing Bell 2Dehaier Medical Systems Chief Executive Officer To Ring NASDAQ Stock Market Closing Bell 3
(Date:8/20/2014)... Caddis Partners LLC, has built one ... real estate company in recent years, developing or acquiring ... $500 million, including more than $100 million last year ... expansions into new geographic regions and a wider array ... pleased to announce an enhanced brand identity that includes ...
(Date:8/20/2014)... US (PRWEB) August 20, 2014 ... access, governmental and physician stakeholders networks impacting the ... Latin America, US, Canada, and Emerging Markets. , ... Heartbeat Experts’ perspectives on stakeholder management needs for ... new immunotherapy and targeted therapy investigational agents that ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 In its latest ... and alcohol treatment program that gets clients off to a ... they can believe in, is highlighting an important and possibly ... heeded by everyone who wants to understand the insidious nature ... of the belief that drug abuse targets a certain socioeconomic ...
(Date:8/20/2014)... August 20, 2014 The Academy of ... Lokhandwala, DDS, FAGD of Starbrite Dental in Fremont, California, ... 2014 Annual Meeting & Exhibits, which took place June ... presented to dentists who seek to provide the highest-quality ... earn this prestigious honor, Dr. Lokhandwala completed 500 hours ...
(Date:8/20/2014)... 20, 2014 (HealthDay News) -- White, straight women are ... minority, bisexual or lesbian women, a new study finds. ... women, aged 21 to 44, who took part in ... the National Survey of Family Growth study. In ... said they sought treatment for infertility. This ranged from ...
Breaking Medicine News(10 mins):Health News:Caddis Rebrands to Emphasize Its Growth, Expanded Capabilities 2Health News:Caddis Rebrands to Emphasize Its Growth, Expanded Capabilities 3Health News:Caddis Rebrands to Emphasize Its Growth, Expanded Capabilities 4Health News:Download HeartBeat Experts White Paper: A Stakeholder Engagement Strategy is Critical for the Evolving Melanoma Treatment Setting 2Health News:New A Forever Recovery Blog Post Reminds People that Drug Abuse Doesn’t Discriminate 2Health News:New A Forever Recovery Blog Post Reminds People that Drug Abuse Doesn’t Discriminate 3Health News:Fremont Dentist Receives Prestigious AGD Fellowship Award 2Health News:White Women More Likely to Seek Fertility Treatment: Report 2
... Ames, Iowa Byron Brehm-Stecher, assistant professor in food ... his work with tiny particles. His latest research project ... silver nanoparticles to improve the safety of the worlds ... directly to foods, the ultimate goal of this project ...
... April 10 Clinsys Clinical Research, a,therapeutically ... launch of Clinsys ALTERNA, which utilizes its ... resource services. The new,division demonstrates Clinsys, commitment ... and the life sciences industry,s continuously evolving,staffing ...
... parents have taken their children to a podiatrist,for foot ... and foot pain bring thousands of adults to doctors, ... by the American,Podiatric Medical Association (APMA) during April,s Foot ... of foot,health when it comes to their children,s feet. ...
... The National,Community Pharmacists Association (NCPA) is endorsing Rep. ... 3rd,Congressional District, who has been a powerful advocate ... patients. He is facing a,challenger in the North ... RPh, executive vice president and CEO of NCPA ...
... April 10 Health Environments Research &,Design Journal ... is to enhance the knowledge and practice of,evidence-based ... trends, and translating research to practice. The,vision of ... result of enhancing,healthcare environments for those receiving and ...
... independent ... auditors, LOUISVILLE, Colo., ... a result of its first Type,II SAS 70 compliance audit. The SAS ... U.S. accounting firm over a,period of five months. The audit covered GHX,s ...
Cached Medicine News:Health News:Iowa State University researcher looks to use nanoparticles for food safety 2Health News:Clinsys(R) Redefines Resource Services with the Launch of Clinsys ALTERNA(TM) 2Health News:Pediatric Survey Reveals Many Parents Neglect Their Children's Feet 2Health News:The Center for Health Design & Vendome Group Unveil Premiere Issue of Health Environments Research & Design Journal (HERD) - http://www.herdjournal.com 2Health News:GHX Achieves SAS 70 Compliance 2
Bi-phasic peristaltic infusion pump for tumescent work....
Inquire...
... Pump provides optimum flow rate ... Operates on any voltage worldwide. ... safety Interlock and easy load ... Double Spike Tubing, Dual Pneumatic ...
... VASER System represents a major advance ... to cosmetic procedures. Combined with precision ... emulsification, a solid grooved probe design ... System has been designed to minimize ...
Medicine Products: